Our R&D plan consists of two programs. Currently more active is the Biomarker program including development of the diagnostic kit. Once the Biomarker program is advanced we will focus on the Drug development program. All the requirements of clinical trials will be rigorously followed in each phase of the development.
1. Progression of the Biomarker program
2. The outline of the Drug development program